Authors

Latest Article

FDA Approves Riptide Aspiration System for Acute Ischemic Stroke

The FDA has approved the Riptide Aspiration System for thrombus retrieval via the Arc Catheter for revascularization in patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease.

Kathryn A. Davis, MD, MS, FAES

Marc R. Nuwer, MD, PhD

Latest Article

Marc Nuwer Explores the 2019 CPT Codes for Epilepsy

7 years ago

The professor and vice chair of the neurology department at UCLA discussed the new VNS, RNS and DBS CPT codes for 2019.

Clyde E. Markowitz, MD, Patricia K. Coyle, MD

Peter Goadsby, MBBS

Chris Mazzolini

Latest Article

Eight Ways to Evaluate a Telehealth Vendor

5 years ago

A look at the questions you should be asking during the decision-making process of picking a telehealth vendor.

Leslie Humbel, BA

Latest Article

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

5 years ago

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.

Jill Jarecki, PhD

Latest Article

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

5 years ago

Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.

Rohit Dhall, MD, MSPH

Latest Article

Noninvasive Neuromodulation for Essential Tremor: An Important Tool for Maintaining Independence at Home

5 years ago

Noninvasive neuromodulation with TAPS is a safe and effective tool that offers particular utility in the age of COVID-19 when other treatment options may be less accessible.

Staff Writer

Latest Article

Gene Therapy Shows Robust Activity for Duchenne Muscular Dystrophy

7 years ago

A novel gene therapy has demonstrated impressive early results in a small sample of 3 children with Duchenne muscular dystrophy.

Mazen Hanna, MD

Stephen Silberstein, MD, Richard B. Lipton, MD

Stephen Silberstein, MD, Peter Goadsby, MBBS

Amy Harper, MD

Richard B. Lipton, MD, Stephen Silberstein, MD

David K. B. Li, MD, FRCPC

Latest Article

The Importance of a Globally Aligned, Standardized MRI Protocol for MS

6 years ago

Leaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.

Richard Trosh, MD

Aaron Boster, MD

Latest Article

Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction

6 years ago

Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.

Sebastian Mills

Suhayl S. Dhib-Jalbut, MD

Kenneth Bender, PharmD, MA

Latest Article

The “Grave Threat” Posed by the Shortage of Neurologists

4 years ago

With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.

Rod Foroozan, MD

Ashley Aaroe, MD

Latest Article

Neurology on the Hill: My Role as an Advocate for Neurology

5 years ago

Neuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.

Rodney A. Radtke, MD

Erica Slaughter, MS

Latest Article

Managing Psychosis in Parkinson Disease: Challenges and Opportunities

6 years ago

Although the indication of pimavanserin has provided some relief, more work remains to improve how physicians diagnose, treat, and manage psychosis symptoms.

Suhayl Dhib-Jalbut, MD

Latest Article

Study Findings Provide New Hope for Patients With Multiple Sclerosis

a year ago

Multiple sclerosis affects nearly 3 million patients worldwide; new research is helping pave the way for developing new therapies and medications that get at the defining mechanisms that trigger immune regulation loss of this unpredictable central nervous system disease.

Matthew J. Baker, MD

James W. Kupiec, MD

Latest Article

Aducanumab's Unlikely Road to the FDA: Is Approval Imminent?

5 years ago

Recent news that the FDA has granted the fastest possible review for Biogen’s Alzheimer disease treatment aducanumab may be indicative of the agency’s increasing confidence in the drug.

Authors

FDA Approves Riptide Aspiration System for Acute Ischemic Stroke

Marc Nuwer Explores the 2019 CPT Codes for Epilepsy

Eight Ways to Evaluate a Telehealth Vendor

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers

Noninvasive Neuromodulation for Essential Tremor: An Important Tool for Maintaining Independence at Home

Gene Therapy Shows Robust Activity for Duchenne Muscular Dystrophy

The Importance of a Globally Aligned, Standardized MRI Protocol for MS

Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction

The “Grave Threat” Posed by the Shortage of Neurologists

Neurology on the Hill: My Role as an Advocate for Neurology

Managing Psychosis in Parkinson Disease: Challenges and Opportunities

Study Findings Provide New Hope for Patients With Multiple Sclerosis

Aducanumab's Unlikely Road to the FDA: Is Approval Imminent?

Trending on NeurologyLive

Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update

2025 Women in Neurology Conference: Educating, Mentoring, and Networking

This Week on NeurologyLive® — September 15, 2025

NeurologyLive® Brain Games: September 14, 2025

10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference